9/29/2022More MNCs Are Partnering with Chinese Drugmakers in Licensing Deals (P...

9/28/20223 Steps to Navigate Rare Disease Market in China (PharmExec)

9/28/2022Parexel Opens Clinical Trial Supplies and Logistics Depot in Suzhou

9/28/2022China's Focus to Develop Domestic Medical Device Industry May Discoura...

9/28/2022Seagen and Zai Lab Enter License Pact for Anticancer TIVDAK in Greater...

9/28/2022China Forms 12th Chinese Pharmacopoeia Commission to Compile 2025 Edit...

9/28/2022MNCs Witnessed China Performance Slump in Q2/2022

9/28/2022Merck and Sinopharm Enter Import/Distribution Deal for Covid Pill Lage...

9/28/2022Simcere and Almirall Enter into a Licensing Agreement for IL-2 mu-Fc

9/27/2022WuXi STA Opens First High Potency Oral Drug Product Manufacturing Faci...

9/27/2022CDE Solicits Comments on Two Draft Guidelines on TCM Registration

9/27/2022CDMO Asymchem Plans CNY 5B Manufacturing Facility in Taixing

9/26/2022KiOmed and Hansoh Enter License Pact for KiOmedinevsOne in Greater Chi...

9/26/2022CASI Pharma Disposes Chinese JV to Strengthen Balance Sheet

9/23/2022IQVIA: Chinese Retail Pharmacy Sales Fell 3.8% in Q2/2022

9/23/2022SMEI: Chinese Retail Pharmacy O2O Development Report 2022

9/23/2022Recent Executive Moves

9/22/2022Moderna 'Eager' to Collaborate with China on Supplying COVID Vaccines

9/22/2022Merck Group Opens Shanghai Biologics Testing Center to Cater for Local...

9/22/2022Amgen Marks Ten Years in China, Set to Speed Up Domestic Growth

9/22/2022The Chosen Few: A Fresh Look at European FDI in China (Rhodium)

9/22/2022COVID Is Undermining China's Bold Plan for Universal Health Care (Nikk...

9/21/2022China Approved Its First Homegrown CD20 Antibody in August (PharmaDJ)

9/21/2022Merck China President Allan Gabor Shares Insights on AI and Biomedicin...

9/21/2022F-star Therapeutics Discloses Extended CFIUS Review for Sino-Biopharma...

9/21/2022PhIIC: Chinese Hospital Drug Sales Fell 4.85% in Q2/2022

9/20/2022Immuno Cure BioTech Acquires Shanghai Teresa Healthcare

9/20/2022SCMP: Biden's Biotech Plan Has Limited Near-Term Impact on Chinese Fir...

9/19/2022NHSA Announces the List of Drugs Passing Preliminary Form Evaluation f...

9/16/2022METiS Enters License Agreement with Voronoi for Pan-RAF Inhibitor

Page:65/361 Total number of articles:10829: [First][<<] [63] [64] [65] [66] [67] [>>] [End]